Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (41-50 of 272) with videos related to

Pageof 28
Sort By:
The Lancet. Oncology|May 30, 2014
Carboplatin plus paclitaxel scheduling for advanced ovarian cancer - authors' replySandro Pignata, Massimo Di Maio, Ciro Gallo, et al.
Global & Regional Health Technology Assessment|January 22, 2026
Claudio Jommi, Barbara Rebesco, Francesco Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Tackling off-label use of anticancer drugsFrancesco Perrone, Filippo de Braud, Roberto Labianca, et al.
JAMA Network Open|January 19, 2023
Patient-Reported Outcome Measures in Oncology Drugs Approved by the European Medicines Agency, 2017-2021Oriana Ciani, Michela Meregaglia, Francesco De Lorenzo, et al.
Tumori|April 21, 2016
The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation processGianfranco De Feo, Francesca D'Ambrosio, Giada Palmieri, et al.
The Lancet. Oncology|October 5, 2011
Zoledronic acid in early-stage breast cancerNicola Normanno, Antonella De Luca, Marianna Gallo, et al.
Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.
Contemporary Clinical Trials Communications|October 12, 2020
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis planPaolo Chiodini, Laura Arenare, Maria Carmela Piccirillo, et al.
Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.
Le Infezioni in Medicina|October 20, 2010
[Community-acquired pneumonia: a budget impact model]Massimo Giusti, Francesco Banfi, Francesco Perrone, et al.
Pageof 28

Showing results (41-50 of 272) with videos related to

Sort By:
Pageof 28
The Lancet. Oncology|May 30, 2014
Carboplatin plus paclitaxel scheduling for advanced ovarian cancer - authors' replySandro Pignata, Massimo Di Maio, Ciro Gallo, et al.
Global & Regional Health Technology Assessment|January 22, 2026
Claudio Jommi, Barbara Rebesco, Francesco Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Tackling off-label use of anticancer drugsFrancesco Perrone, Filippo de Braud, Roberto Labianca, et al.
JAMA Network Open|January 19, 2023
Patient-Reported Outcome Measures in Oncology Drugs Approved by the European Medicines Agency, 2017-2021Oriana Ciani, Michela Meregaglia, Francesco De Lorenzo, et al.
Tumori|April 21, 2016
The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation processGianfranco De Feo, Francesca D'Ambrosio, Giada Palmieri, et al.
The Lancet. Oncology|October 5, 2011
Zoledronic acid in early-stage breast cancerNicola Normanno, Antonella De Luca, Marianna Gallo, et al.
Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.
Contemporary Clinical Trials Communications|October 12, 2020
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis planPaolo Chiodini, Laura Arenare, Maria Carmela Piccirillo, et al.
Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.
Le Infezioni in Medicina|October 20, 2010
[Community-acquired pneumonia: a budget impact model]Massimo Giusti, Francesco Banfi, Francesco Perrone, et al.
Pageof 28